Since then, the demand for these drugs has skyrocketed, with a marked surge in GLP-1RA prescriptions for weight loss management
by mid-2025, spend had reached over $7 billion across the GLP-1 class
When treatments were initiated, mice had ad libitum access to food, water, and kaolin pellets
(September 2023) Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis (September 2023) As Semaglutides Popularity Soars, Rare but Serious Adverse Effects Are Emerging (November 2023) Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the UglyBenefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying (January 2024) Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain (May 2024) Other Possible Side Effects of Zepbound Explored Tirzepatide, the active ingredient in Zepbound, belongs to a class of drugs called GLP-1 agonists
Pregnancy and breastfeeding
C.AzumaJ